Biotech Values

[DewDiligence]

Look out if Martin Shkrekli gives a nod to WGBS. Could see another KBIO in the making.

Although other busted biotech companies (e.g. MCUR) are likely do a reverse merger to allow a private company to go public via the back door, I wouldn’t bet on a repeat performance of KBIO, which is an altogether different kind of animal.